Fibrotic Tumors in a Clinical Array of PDAC Can be Selectively Identified and Monitored by Collagen Hybridizing Peptides

Introduction

Pancreatic Ductal Adenocarcinoma (PDAC) remains a formidable challenge in oncology; characterized by its aggressive nature, early metastasis, and resistance to conventional therapeutic modalities. Despite being one of the most fatal cancers, PDAC research and treatment development have been hampered by the inability to make early diagnoses, improved clinical prognoses, and create effective treatment plans.

Citations